Okay, get this: A drug designed for Hepatitis C might actually be the secret weapon against Hepatitis E. Seriously. This is huge because Hepatitis E kills about 70,000 people every year, and right now, there’s no specific treatment for it.
While most healthy folks shake off Hepatitis E, it can be really nasty for people with weak immune systems. Think organ transplant patients, or pregnant women – for them, it can be deadly. But now, scientists have found that a drug called bemnifosbuvir could stop the virus from multiplying.
The Clever Discovery
An international team from Germany and China stumbled upon bemnifosbuvir. They were sifting through a bunch of molecules that look like the building blocks of genetic material. They found this particular one could trick the virus.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxDr. Mara Klöhn from Ruhr University Bochum explained that these lab-made molecules are kind of like decoys. They look like the stuff our bodies use, but also like what viruses use to make copies of themselves.
They tested about 500 different compounds. To see which ones worked, they used a special version of the virus that glows. If the glow faded, it meant the virus wasn't reproducing. And guess what? Bemnifosbuvir shut it down, all while keeping the treated cells healthy.
Jungen Hu from Heidelberg University shared that the drug completely stopped the virus from replicating. Even better, follow-up studies in animals showed the drug not only lowered the amount of virus but also reduced liver swelling. That's a double win.
Here’s why that matters: Bemnifosbuvir is already in human trials for Hepatitis C. If it gets the green light for C, doctors could start using it “off-label” for Hepatitis E much, much faster than if they had to develop a brand new drug from scratch. That could save a lot of lives, really soon.
